[A Case of Angioimmunoblastic T-cell Lymphoma (AITL)]. 2022

Ayaka Kaneoka, and Yoko Akamatsu, and Reiko Hara, and Akiko Sugiyama, and Mihoko Setoguchi
Department of Dermatology, University of Occupational and Environmental Health, Japan.

A 84-year-old female noticed erythema over her whole body for several months and was referred to our department for evaluation of her skin eruption. A physical examination revealed millet-sized erythematous papules and macules all over her body, a high body temperature, and a decreased level of consciousness. A laboratory examination showed an elevated white blood cell count (8200/μl), atypical lymphocytes (3%) and sIL-2R (4030U / ml). Computed Tomography showed systemic lymphadenopathy. A lymph node biopsy taken from the left inguinal lymph node revealed destruction of the lymph nodes, enlargement of the high endothelial venules, and atypical lymphocyte infiltration. Based on the clinical findings and laboratory examination, we diagnosed angioimmunoblastic Tcell lymphoma (AITL). AITL is a relatively rare peripheral T-cell lymphoma with severe systemic symptoms such as fever and lymph node swelling. While approximately half of all cases experience skin symptoms, which are one of the initial symptoms, it is difficult to determine the diagnosis due to the various clinical features or many non-specific rashes. We should keep in mind a differential diagnosis of lymphoma in cases of the presence of persistent eruption, systemic symptoms, and the existence of atypical lymphocytes in peripheral blood.

UI MeSH Term Description Entries
D007119 Immunoblastic Lymphadenopathy A disorder characterized by proliferation of arborizing small vessels, prominent immunoblastic proliferations and amorphous acidophilic interstitial material. Clinical manifestations include fever, sweats, weight loss, generalized lymphadenopathy and frequently hepatosplenomegaly. Angioimmunoblastic Lymphadenopathy,Lymphadenopathy, Immunoblastic,Angioimmunoblastic Lymphadenopathies,Immunoblastic Lymphadenopathies,Lymphadenopathies, Angioimmunoblastic,Lymphadenopathies, Immunoblastic,Lymphadenopathy, Angioimmunoblastic
D008198 Lymph Nodes They are oval or bean shaped bodies (1 - 30 mm in diameter) located along the lymphatic system. Lymph Node,Node, Lymph,Nodes, Lymph
D003937 Diagnosis, Differential Determination of which one of two or more diseases or conditions a patient is suffering from by systematically comparing and contrasting results of diagnostic measures. Diagnoses, Differential,Differential Diagnoses,Differential Diagnosis
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000072281 Lymphadenopathy Disease of LYMPH NODES which are abnormal in size, number or consistency. Adenopathy,Adenopathies,Lymphadenopathies
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old
D016411 Lymphoma, T-Cell, Peripheral A group of malignant lymphomas thought to derive from peripheral T-lymphocytes in lymph nodes and other nonlymphoid sites. They include a broad spectrum of lymphocyte morphology, but in all instances express T-cell markers admixed with epithelioid histiocytes, plasma cells, and eosinophils. Although markedly similar to large-cell immunoblastic lymphoma (LYMPHOMA, LARGE-CELL, IMMUNOBLASTIC), this group's unique features warrant separate treatment. Peripheral T-Cell Lymphoma,T-Cell Lymphoma, Peripheral,Lymphoma, T Cell, Peripheral,Lymphoma, Peripheral T-Cell,Lymphomas, Peripheral T-Cell,Peripheral T Cell Lymphoma,Peripheral T-Cell Lymphomas,T Cell Lymphoma, Peripheral,T-Cell Lymphomas, Peripheral

Related Publications

Ayaka Kaneoka, and Yoko Akamatsu, and Reiko Hara, and Akiko Sugiyama, and Mihoko Setoguchi
September 2002, [Rinsho ketsueki] The Japanese journal of clinical hematology,
Ayaka Kaneoka, and Yoko Akamatsu, and Reiko Hara, and Akiko Sugiyama, and Mihoko Setoguchi
May 2024, Journal of neurology,
Ayaka Kaneoka, and Yoko Akamatsu, and Reiko Hara, and Akiko Sugiyama, and Mihoko Setoguchi
April 2021, Seminars in hematology,
Ayaka Kaneoka, and Yoko Akamatsu, and Reiko Hara, and Akiko Sugiyama, and Mihoko Setoguchi
July 2007, The American journal of surgical pathology,
Ayaka Kaneoka, and Yoko Akamatsu, and Reiko Hara, and Akiko Sugiyama, and Mihoko Setoguchi
May 2022, Cureus,
Ayaka Kaneoka, and Yoko Akamatsu, and Reiko Hara, and Akiko Sugiyama, and Mihoko Setoguchi
January 2019, Frontiers in oncology,
Ayaka Kaneoka, and Yoko Akamatsu, and Reiko Hara, and Akiko Sugiyama, and Mihoko Setoguchi
June 2022, Cancers,
Ayaka Kaneoka, and Yoko Akamatsu, and Reiko Hara, and Akiko Sugiyama, and Mihoko Setoguchi
July 2021, Clinical lymphoma, myeloma & leukemia,
Ayaka Kaneoka, and Yoko Akamatsu, and Reiko Hara, and Akiko Sugiyama, and Mihoko Setoguchi
January 2022, Leukemia,
Ayaka Kaneoka, and Yoko Akamatsu, and Reiko Hara, and Akiko Sugiyama, and Mihoko Setoguchi
April 2006, The American journal of surgical pathology,
Copied contents to your clipboard!